NeuroBo Pharmaceuticals, Inc. has announced its official launch, marking the start of its efforts in developing treatments for significant unmet patient needs including diabetic neuropathic pain and Alzheimer’s disease. The company is led by John L. Brooks III, co-founder of seven life sciences companies, and former chief executive officer of the Joslin Diabetes Center. Richard Kang, PhD is a co-founder and chief operating officer. Dr. Roy Freeman is the Chair of the Scientific Advisory Board...